Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

NASDAQ ($NDAQ) Releases Q1 2026 Earnings

None

NASDAQ ($NDAQ) posted quarterly earnings results for Q1 2026 on Thursday, April 23rd. The company reported earnings of $0.96 per share, beating estimates of $0.95 by $0.01. The company also reported revenue of $1,407,000,000, beating estimates of $1,398,135,848 by $8,864,152.

You can see Quiver Quantitative's $NDAQ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive NDAQ Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

NASDAQ Insider Trading Activity

NDAQ Insider Trades

NASDAQ insiders have traded $NDAQ stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:

  • AB INVESTOR purchased 200,000 shares for an estimated $15,835,040
  • ADENA T FRIEDMAN (Chair and CEO) sold 113,611 shares for an estimated $9,706,923
  • JOHN ZECCA (EVP, Global CLO) sold 4,500 shares for an estimated $450,045
  • BRYAN EVERARD SMITH (EVP, CPO) sold 4,633 shares for an estimated $419,610
  • JEREMY SKULE (EVP, CSO) has made 0 purchases and 2 sales selling 4,210 shares for an estimated $370,416.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NASDAQ Hedge Fund Activity

We have seen 512 institutional investors add shares of NASDAQ stock to their portfolio, and 480 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NASDAQ Congressional Stock Trading

Members of Congress have traded $NDAQ stock 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NASDAQ Analyst Ratings

Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/30/2026
  • JP Morgan issued a "Overweight" rating on 01/30/2026
  • Morgan Stanley issued a "Overweight" rating on 01/15/2026

To track analyst ratings and price targets for NASDAQ, check out Quiver Quantitative's $NDAQ forecast page.

NASDAQ Price Targets

Multiple analysts have issued price targets for $NDAQ recently. We have seen 7 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $108.0.

Here are some recent targets:

  • Benjamin Budish from Barclays set a target price of $114.0 on 04/13/2026
  • Chris Allen from Keefe, Bruyette & Woods set a target price of $92.0 on 04/08/2026
  • Bill Katz from TD Cowen set a target price of $106.0 on 02/26/2026
  • Michael Cyprys from Morgan Stanley set a target price of $116.0 on 01/30/2026
  • Michael Cho from JP Morgan set a target price of $101.0 on 01/30/2026
  • Ashish Sabadra from RBC Capital set a target price of $108.0 on 01/30/2026
  • Alex Kramm from UBS set a target price of $120.0 on 01/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles